At a glance
- Originator Ipsen
- Class Cytostatics; Phospholipids
- Mechanism of Action Cell membrane permeability inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 27 Feb 2001 Discontinued-Preclinical for Cancer in France (Unknown route)
- 23 Oct 1997 No-Development-Reported for Cancer in France (Unknown route)